Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 220 participants.
Also called NCT06207383
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 220 participants
- Registry
-
NCT06207383
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Austria, Belgium, Bulgaria, Czechia, Finland, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT06207383. Randomized; single masking; primary purpose treatment. Start 2024-10-01 (actual); primary completion 2028-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
- Acronym
- ABACUS
- Condition
- Atrial Fibrillation, Persistent
- Condition
- Heart Failure
- Intervention (Device)
- Conduction system pacing
- Intervention (Procedure)
- Atrioventricular nodal ablation
- Intervention (Procedure)
- Atrial fibrillation ablation
- Lead sponsor
- University Hospital, Geneva
- Collaborator
- Swiss National Science Foundation
Record details
- Record id
cardio:ct-nct06207383- Content hash
d2311e7ab64d779bfabc08b9e1b8edcca500abf1895806a3e9a39cc637dc38af